-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GxHlX98Ty71PObEftJ8ecetzCAclHCNq204R8lakjrDA+uBE+53wFMfjGbxUegTr
 OzjoQS3afOmU0KRvFbNxgw==

<SEC-DOCUMENT>0000950123-10-099874.txt : 20101103
<SEC-HEADER>0000950123-10-099874.hdr.sgml : 20101103
<ACCEPTANCE-DATETIME>20101103105454
ACCESSION NUMBER:		0000950123-10-099874
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20101102
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20101103
DATE AS OF CHANGE:		20101103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EZCORP INC
		CENTRAL INDEX KEY:			0000876523
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-MISCELLANEOUS RETAIL [5900]
		IRS NUMBER:				742540145
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19424
		FILM NUMBER:		101160340

	BUSINESS ADDRESS:	
		STREET 1:		1901 CAPITAL PKWY
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
		BUSINESS PHONE:		5123143400

	MAIL ADDRESS:	
		STREET 1:		1901 CAPITAL PKWY
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d77410e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>








<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">
<DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>


<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">
<DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported): November&nbsp;2, 2010</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">
<DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>


<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>EZCORP, Inc.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">
(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction of incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>0-19424</B><BR>
(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>74-2540145</B><BR>
(IRS Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">
<B>1901 Capital Parkway, Austin, Texas 78746</B><BR>

(Address of principal executive offices)&nbsp;&nbsp;&nbsp;(zip code)</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 12pt">
Registrant&#146;s telephone number, including area code: (<B>512) 314-3400</B></DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD valign="top"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)
</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD valign="top"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)
</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD valign="top"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD valign="top"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</TD>
</TR>
</TABLE>
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>











<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<!-- link2 "Item&nbsp;5.02 &#151; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Item&nbsp;5.02 &#151; Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers</B></DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>On November&nbsp;2, 2010, EZCORP, Inc. announced the appointment of Stephen A. Stamp as Senior
Vice President and Chief Financial Officer (principal financial officer), effective
immediately. A copy of the company&#146;s press release announcing this appointment is attached as
Exhibit&nbsp;99.1 and incorporated herein by reference.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Mr.&nbsp;Stamp, age 48, has over 27&nbsp;years of finance and business experience, having previously
served as Chief Financial Officer and Chief Operating Officer of Xanodyne Pharmaceuticals;
Group Finance Director at Regus Group PLC; and Group Finance Director at Shire
Pharmaceuticals Group PLC. Mr.&nbsp;Stamp&#146;s career also includes various roles at Lazard Brothers
&#038; Company Ltd. and KPMG. Most recently, Mr.&nbsp;Stamp served as Chief Financial Officer at KV
Pharmaceutical Company.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Under the terms of his employment, Mr.&nbsp;Stamp will receive an annual salary of $350,000, a
target bonus of 60% of base salary, and 20,000 restricted shares of EZCORP Class&nbsp;A Non-Voting
Common Stock, which will vest pro rata on the first, second and third anniversaries of the
date of grant (assuming continued employment). Mr.&nbsp;Stamp will also be eligible for
relocation benefits and other benefits typically provided to the company&#146;s executive
officers. These benefits include a severance plan that provides for salary continuation for
a period one year if the company terminates Mr.&nbsp;Stamp&#146;s employment without cause.</TD>
</TR>

</TABLE>
</DIV>
<!-- link2 "Item&nbsp;9.01 Financial Statements and Exhibits." -->

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;9.01</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Financial Statements and Exhibits.</B></TD>
</TR>
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Exhibits.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD valign="top" style="font-size: 10pt">&nbsp;</TD>
    <TD valign="top" style="font-size: 10pt"><DIV style="margin-left:0px; text-indent:-0px">Press Release, dated November&nbsp;2, 2010</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<!-- link1 " SIGNATURES" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">EZCORP, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">Date:  November 2, 2010&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Thomas H. Welch, Jr.
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Thomas H. Welch, Jr.&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Senior Vice President,
General Counsel and Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<!-- link1 " EXHIBIT INDEX" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT INDEX</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibit</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">99.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD valign="top" style="font-size: 10pt">&nbsp;</TD>
    <TD valign="top" style="font-size: 10pt"><DIV style="margin-left:0px; text-indent:-0px">Press Release, dated November&nbsp;2, 2010</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d77410exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;99.1</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="d77410d7741000.gif" alt="(EZCORP LOGO)">
</DIV>


<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>EZCORP ANNOUNCES NEW CHIEF FINANCIAL OFFICER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">AUSTIN, Texas (November&nbsp;2, 2010) &#151; EZCORP, Inc. (Nasdaq: EZPW) announced today the
appointment of Stephen A. Stamp as Senior Vice President and Chief Financial Officer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Mr.&nbsp;Stamp has over 27&nbsp;years of finance and business experience. Most recently, Mr.&nbsp;Stamp served as
Chief Financial Officer at KV Pharmaceutical Company, a U.S. based manufacturer of generic and
branded drugs. He previously spent five years at Xanodyne Pharmaceuticals, a U.S. based specialty
pharmaceutical company, where he served as Chief Financial Officer and for one year as Chief
Operating Officer. Prior to his time at Xanodyne, Mr.&nbsp;Stamp spent over three years as Group
Finance Director at Regus Group PLC, a publicly traded, United Kingdom based office services
company with operations in over 50 countries; and six years as Group Finance Director at Shire
Pharmaceuticals Group PLC, a publicly traded international specialty pharmaceutical company
headquartered in the U.K. Mr.&nbsp;Stamp&#146;s career also includes various roles at Lazard Brothers &#038;
Company Ltd. and KPMG. Mr.&nbsp;Stamp graduated from the University of Manchester with a degree in
Business Finance. He is a Chartered Accountant in the U. K.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Paul Rothamel, EZCORP&#146;s President and Chief Executive Officer, stated: &#147;Stephen is a seasoned
executive who not only brings great finance and accounting experience, but is also a proven
business leader well versed in both U.S. and international issues. Stephen has led a variety of
finance organizations and has managed numerous complex financing transactions, acquisitions,
systems integrations, and cost-containment initiatives. I am excited to add such a successful
operational leader and proven strategic thinker to my executive leadership team. His contributions
will be invaluable as we continue the strategic growth of EZCORP.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About EZCORP</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">EZCORP is a leading pawn store operator and provider of specialty consumer financial services.
It provides collateralized non-recourse loans, commonly known as pawn loans, and a variety of
short-term consumer loans, including payday loans, installment loans and auto title loans, or
fee-based credit services to customers seeking loans. At its pawn stores, the company also sells
merchandise, primarily collateral forfeited from its pawn lending operations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">EZCORP operates more than 1,000 stores, including more than 500 pawn stores in the U.S. and Mexico
and more than 500 short-term consumer loan stores in the U.S. and Canada. The Company also has
significant investments in Albemarle &#038; Bond Holdings PLC (ABM.L), one of the U.K.&#146;s largest
pawnbroking businesses with over 120 stores, and Cash Converters International Limited (CCV.L and
CCV.AUS), which franchises and operates a worldwide network of over 500 stores that provide
financial services and sell pre-owned merchandise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For additional information, contact Investor Relations at (512)&nbsp;314-2220.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>d77410d7741000.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 d77410d7741000.gif
M1TE&.#EAH0`>`/<``("(YH":YJ:X[;7$\+S*\<;1\\W7]=/<]MGA]][D^./H
M^>?K^NON^_'T_/;X_?___Y#I()$#*)#?&I&`A?___Y%?K)?O!!+A;)?NR!+9
M=!+98```&````!+9.```0````````!+9=!+98````````5\`X!H`1!F)V"4>
MG!+;_%]3:`)P```"]``"Y````````#X`/!+9<%\```$``SH`0U<`7$X`24\`
M1%,`5W,`7',`>64`=#,`;5P`,G,`36T`:68`=&0`+FP`;```````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````!+;>%\/Z)-TNA+;7%]3:````!4```(`"0`!>&8`
M"``!=P```````5]34````!A&^!+</)$`70`!-0```%]3:`"\VQ+;@)#I(!+<
M#)#I()$M@/___Y$M>)%I#@```>`$D9%HU@```````%]3:!8`/)?NR```````
M``@``)?LP)?NR!+A;!+A;.`$D1+<`!+A9E]3:``````!-1+<-)#V7)#V80`!
M-0```%]3:!+<$)%FN!+<>)#I(``!-0``?A+<1("4,!+A+!+A,````!+<>)#V
M7)#V80```!+A,!+A+!+<5%]3:!+@_)#I(```````?A+<B("4,```?A+A,!+A
M#(#G<H#FRP!`!5Z"2````"'Y!```````+`````"A`!X`AX"(YH":YJ:X[;7$
M\+S*\<;1\\W7]=/<]MGA]][D^./H^>?K^NON^_'T_/;X_?___Y#I()$#*)#?
M&I&`A?___Y%?K)?O!!+A;)?NR!+9=!+98```&````!+9.```0````````!+9
M=!+98````````5\`X!H`1!F)V"4>G!+;_%]3:`)P```"]``"Y````````#X`
M/!+9<%\```$``SH`0U<`7$X`24\`1%,`5W,`7',`>64`=#,`;5P`,G,`36T`
M:68`=&0`+FP`;```````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````````````!+;>%\/Z)-T
MNA+;7%]3:````!4```(`"0`!>&8`"``!=P```````5]34````!A&^!+</)$`
M70`!-0```%]3:`"\VQ+;@)#I(!+<#)#I()$M@/___Y$M>)%I#@```>`$D9%H
MU@```````%]3:!8`/)?NR`````````@``)?LP)?NR!+A;!+A;.`$D1+<`!+A
M9E]3:``````!-1+<-)#V7)#V80`!-0```%]3:!+<$)%FN!+<>)#I(``!-0``
M?A+<1("4,!+A+!+A,````!+<>)#V7)#V80```!+A,!+A+!+<5%]3:!+@_)#I
M(```````?A+<B("4,```?A+A,!+A#(#G<H#FRP!`!5Z"2`````C^`!\('$BP
MH,&#"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'(E108"3*%.J1'E@
MH,F5,%.V1*@`00$!*`<84/"P08("`U(6.,!`X<N8*0<4X&GP*-(`!1)8-/`T
M9E&!5*NNO$K0P0&<2`4T6)@@Z-,!8P]FU8I2;,&U6@E49*M2`$&Z*>T63$#7
M[4$&8-ERO8L7I8&"A0/,C.B4[N+&;!<+)%#XL,$#B?42A$QW<^(!$^'2Y2J:
M;=K)B0,8I)R:Z<#2G5^GGKA2\T6^=4\_8)V4:8/`*747@(D@;0/8E@?6+MB`
M=T[">0<V,"M4(F3)%4L3<$`0LTJYGE?^GD:PDH!N@<-5%@@OTR#N]@*O$R2O
M$H'$TH,G-E^)O4%Y@_ZUM9-TRQWT'DKKR:92?KN)IV!*@Z4'H429,0382JX-
M1!U*YSW0W`$*<%>0A!S2M%)R#Q0H4`,*.'<2BBIZN!)H#P!@(P`,<?84=N[5
MUB$#)T848'4('7B25/&E%H!M\CW@0`+`G:2`C03AJ)"+6G5(D'8BOK551/@E
MA.5I6&J%%D%E/E4`CC=2:>5!#GR6T'XJH=C5C!'%J1*-<.(ID)Z5%00H77*Q
M.1"5">F(E'U_11D`D@<U^9"D/=;G$EX"'-"AHC`56F.;-5[I8$1&+LG@EE^N
M1I1:&":TX4G^7:8)4X*KX86DH:'FVN>>]Y6G)9HK=7GI29D.-F:1_`TTZ$DT
M<D:KLF8.>.B;GQJU$J,.T9F2G0C!!*"CD,*DY6]U=0D9MO2I).P#YS;4)K4(
M'>O0A2I!NI"X7;T:`'@"P<0CN2IE**^,K0*KTJ\5+1L`GPR5*L"I".EK7GR.
M"B!LF0F(V(!W*DFF,,,/.(KBQQYQ&A.C)I_<76KGI5L8=NT21"*S[*&$[4:R
M(I56SCH3-"1;?MV9V,VH';P73+&.NI'"9OZI),@/N/S4Q)'B-0"#)#,'$U-9
M<Y3RM4FF1K1`4M=F;Z2.[IEAS2>-G6*R[(+=$<_X-L@R0D\")=0DJ@XI<`")
@2B6`L-W!'33SPD473M+BC#?N^..01R[YY)17OE!``#L_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
